PCBMI

Total 131
¹øÈ£ Á¦   ¸ñ ±Û¾´ÀÌ ³¯Â¥ Á¶È¸
°øÁö Æ÷½ºÅØ-°¡Å縯´ë ÀÇ»ý¸í°øÇבּ¸¿ø °³ÀÎÁ¤º¸Ã³¸®¹æÄ§ Á¦Á¤ °øÁö ÃÖ°í°ü¸®ÀÚ 2021-03-25 339
°øÁö [°ø°í] 2021³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í<~2/26(±Ý)> ÃÖ°í°ü¸®ÀÚ 2021-02-08 681
131 Æ÷½ºÅØ-°¡Å縯´ë ÀÇ»ý¸í°øÇבּ¸¿ø °³ÀÎÁ¤º¸Ã³¸®¹æÄ§ Á¦Á¤ °øÁö ÃÖ°í°ü¸®ÀÚ 2021-03-25 339
130 [°ø°í] 2021³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í<~2/26(±Ý)> ÃÖ°í°ü¸®ÀÚ 2021-02-08 681
129 [°ø°í] 2020³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í<~2/21(±Ý)> ÃÖ°í°ü¸®ÀÚ 2020-02-03 3130
128 PoCa Research Village Night °³ÃÖ ¾È³» ÃÖ°í°ü¸®ÀÚ 2020-01-10 3183
127 [Æ÷-°¡ °øµ¿¿¬±¸ÆÀ ÃÊû ¼¼¹Ì³ª] Peptides from Hemostatic Effects to Gene Delivery_Ȳº´Èñ ±³¼ö(ÀÎõ´ë,¡¦ ÃÖ°í°ü¸®ÀÚ 2019-12-24 2990
126 [Æ÷-°¡ ¿¬±¸¿ø ÃÊû¼¼¹Ì³ª] Àú°­µµ ÁýÁßÃÊÀ½ÆÄ¸¦ ÀÌ¿ëÇÑ ºñħ½ÀÀû ³ú±â´É Á¶Àý ¿¬±¸(¹Ú»óÀÎ ¹Ú»ç, ÀÎõ¼º¸ð¡¦ ÃÖ°í°ü¸®ÀÚ 2019-11-05 2991
125 [Æ÷-°¡ ¿¬±¸¿ø °øµ¿¿¬±¸ÆÀ ÃÊû ¼¼¹Ì³ª] Overview of cancer immunotherapy_µµÁØ»ó ±³¼ö(¼­¿ï´ë)_07/23(È­)¡¦ ÃÖ°í°ü¸®ÀÚ 2019-07-15 3207
124 ¼­¿ï¼º¸ðº´¿ø ¾Ïº´¿ø-Æ÷½ºÅØ °øµ¿ ½ÉÆ÷Áö¿ò °³ÃÖ ¾È³» ÃÖ°í°ü¸®ÀÚ 2019-06-25 3158
123 [Æ÷-°¡ ¿¬±¸¿ø °øµ¿¿¬±¸ÆÀ ÃÊû¼¼¹Ì³ª] ½ÅÀÇ·á±â¼úÆò°¡ Á¦µµÀÇ ÀÌÇØ_5/21(È­) 17½Ã, Çѱ¹º¸°ÇÀǷῬ±¸¿ø ±è¡¦ ÃÖ°í°ü¸®ÀÚ 2019-05-21 2700
122 2019³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í[~2/22(±Ý)] ÃÖ°í°ü¸®ÀÚ 2019-02-11 1376
121 [Æ÷-°¡ ¿¬±¸¿ø ÃÊû ¼¼¹Ì³ª] TRANSPORT PHENOMENA UNDER NANOSCALE CONFINEMENT, Æ÷½ºÅØ ±â°è°øÇаú ¹ÚÇü±Ô¡¦ ÃÖ°í°ü¸®ÀÚ 2019-01-21 3167
120 PoCa Research Village Night °³ÃÖ ¾È³» ÃÖ°í°ü¸®ÀÚ 2019-01-18 3071
119 ¼­¿ï¼º¸ðº´¿ø ¾Ïº´¿ø-Æ÷½ºÅØ °øµ¿ ½ÉÆ÷Áö¿ò °³ÃÖ ¾È³»(2018.11.23, Æ÷½ºÅØ Ã¶°­´ëÇпø ´ë°­´ç) ÃÖ°í°ü¸®ÀÚ 2018-10-29 3247
118 [Æ÷-°¡ ¿¬±¸¿ø ÃÊû ¼¼¹Ì³ª] Æ÷½ºÅØ ÀÌÀ¯Á¤ & ÀÌÁ¤¿í ±³¼ö ÃÊû ¼¼¹Ì³ª ÃÖ°í°ü¸®ÀÚ 2018-08-20 4044
117 Æ÷-°¡ °øµ¿¿¬±¸ÆÀ ÃÊû ¼¼¹Ì³ª_Power to the patient?_Dr.Gantner(MD, Ph.D, MBA, LL.M.) ÃÖ°í°ü¸®ÀÚ 2018-06-19 3839
 1  2  3  4  5  6  7  8  9  

Á¦¸ñ ¾øÀ½